Our study also suggests that CXCL16 is a promising high-grade UC marker, independent of UC history because AUC for high-grade UC in both primary and recurrent cancers was high (AUC 0.875 – 0.783) compared to the hospital controls (Figure 2D). Here, CXCL16 is linked to cancer.